@article{9c36bcec3fe3460893fd891d4f409c9f,
title = "Translating noninvasive molecular responses into clinical reality for cancer immunotherapy",
author = "Murray, {Joseph C.} and Valsamo Anagnostou",
note = "Funding Information: V.A. receives research funding from Bristol–Myers Squibb. J.C.M. declares no competing interests. Funding Information: The work of the authors is supported in part by the US National Institutes of Health grant CA121113 (V.A.), the Bloomberg-Kimmel Institute for Cancer Immunotherapy (J.C.M. and V.A.), the V Foundation (V.A.), the LUNGevity Foundation (V.A.), the Emerson Collective Cancer Research Fund (V.A.), the Conquer Cancer Foundation Young Investigators Award (J.C.M.), and the US National Cancer Institute T32 training grant CA009071 (J.C.M.).",
year = "2021",
month = feb,
doi = "10.1038/s41571-020-00450-4",
language = "English (US)",
volume = "18",
pages = "65--66",
journal = "Nature Reviews Clinical Oncology",
issn = "1759-4774",
number = "2",
}